Aurelie Garant, M.D.
Assistant Professor

Medical School

Université Laval, Canada (2012)

Residency

McGill University Health Centre (2017), Radiation Oncology

Fellowship

Mayo Clinic (2018), Advanced Radiation Oncology

• Bladder cancer in women
• Prostate cancer protocols
• RCC spine metastases
• Rectal cancer in elderly patients

Featured Publications

A comparison of grade 4 lymphopenia with proton versus photon radiotherapy for esophageal cancer. Advances in radiation oncology

Routman DM, Garant A, Lester SC, Cristobal CT, Yoon HH, Neben-Wittich MA, Martenson JA, Haddock MG, Hallemeier CL, Merrell KW 2019 4 1 63-69

Image-guided adaptive endorectal brachytherapy in the nonoperative management of patients with rectal cancer

Garant A, Magnan S, Devic S, Martin AG, et al Int J Radiat Oncol Biol Phys 2019 105 5 1005-1011

Stereotactic ablative radiation therapy (SAbR) used to defer systemic therapy in oligometastatic renal cell cancer

Zhang Y, Schoenhals J, Christie A, Mohamad O, Wang C, Bowman IA, Singla N, Hammers H, Courtney KD, Bagrodia A, Margulis V, Desai NB, Garant A, Choy H, Timmerman RD, Brugarolas JB, Hannan R. Int J Radiat Oncol Biol Phys 2019 105 2 367-375

A comparison of patient-reported health-related quality of life during proton versus photon chemoradiotherapy for esophageal cancer

Garant A, Whitaker TJ, Spears GM, Routman DM, Harmsen WS, Wilhite TJ, Ashman JB, Sio TT, Rule WG, Neben Wittich MA, Martenson JA, Tryggestad EJ, Yoon HH, Blackmon SS, Merrell KW, Haddock MG, Hallemeier CL Pract Radiat Oncol 2019 9 6 410-417

Addition of iodinated contrast to rectal hydrogel spacer to facilitate MRI-independent target delineation and treatment planning for prostate cancer

Atluri PS, Gannavarapu BS, Timmerman RD, Garant A, Hannan R, Folkert MR, Desai NB Pract Radiat Oncol 2019 9 6 528-533

Optimization of HDRBT boost dose delivery for patients with rectal cancer

Devic S, Bekerat H, Garant A, Vuong T Brachytherapy 2019 18 4 559-563

What Is the Optimal Radiation Technique for Esophageal Cancer? A Dosimetric Comparison of Four Techniques.

Fawaz ZS, Kazandjian S, Tsui JM, Devic DS, Lecavalier-Barsoum M, Vuong T, Elakshar S, Garant A, Lavoie I, Niazi TM Cureus 2018 Jul 10 7 e2985

Do clinical criteria reflect pathologic complete response in rectal cancer following neoadjuvant therapy?

Garant A, Florianova L, Gologan A, Spatz A, Faria J, Morin N, Vasilevsky CA, Vuong T Int J Colorectal Dis 2018 Jun 33 6 727-733

Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with hematologic or solid neoplasms: A systematic review.

Garant A, Guilbault C, Ekmekjian T, Greenwald Z, Murgoi P, Vuong T Crit. Rev. Oncol. Hematol. 2017 Dec 120 86-92

Long-term Outcomes of Induction Carboplatin and Gemcitabine Followed by Concurrent Radiotherapy With Low-dose Paclitaxel and Gemcitabine for Stage III Non-small-cell Lung Cancer.

Guilbault C, Garant A, Faria S, Owen S, Ofiara L, Duclos M, Hirsh V, Kopek N Clin Lung Cancer 2017 09 18 5 565-571

• Texas Super Doctors, Rising Star Award
  (2020)
• NIH Kidney Cancer SPORE Career Enhancement Program Award
  (2019)
• UT Southwestern Leaders Emerging in Academic Departments (LEAD) Course: Class of 2019
  (2019)
• American Brachytherapy Society Prostate LDR/HDR Scholarship
  (2018)
• Reviewer (by invitation), International Journal of Radiation Oncology Biology Physics
  (2018)
• John D. Earle Radiation Oncology Fellowship Fund, Mayo Clinic, Rochester MN
  (2017-2018)
• McGill University Residency Program Award, Scholar
  (2015-2016)

• Diploma of the Royal College of Physicians and Surgeons of Canada - Focused Competency in Brachytherapy (2020)
• American Board of Radiology: Radiobiology/Physics, Clinical Written and Oral Examinations (DABR) (2016-2018)